PRESS RELEASE published on 10/07/2025 at 07:30, 7 months 4 days ago Informations privilégiées / Autres communiqués
BRIEF published on 10/06/2025 at 14:59, 7 months 4 days ago Symbiosis LLC réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuils Cession D'actions MaaT Pharma Symbiosis LLC
BRIEF published on 10/06/2025 at 14:59, 7 months 4 days ago Symbiosis LLC Reduces Stake in MAAT PHARMA Voting Rights Crossing Thresholds Transfer Of Shares MaaT Pharma Symbiosis LLC
PRESS RELEASE published on 10/06/2025 at 14:54, 7 months 4 days ago Franchissements de seuils Déclarations de franchissements de seuils par Symbiosis LLC1 concernant MAAT PHARMA publiées par l'AMF le 3 octobre 2025 AMF Franchissements De Seuils MaaT Pharma Régularisation Symbiosis LLC1
BRIEF published on 09/17/2025 at 07:35, 7 months 24 days ago MaaT Pharma dévoile ses résultats semestriels 2025 Résultats Semestriels MaaT013 Efficacité Accord Clinigen Financement BEI Croissance Revenus
BRIEF published on 09/17/2025 at 07:35, 7 months 24 days ago MaaT Pharma unveils its 2025 half-year results Revenue Growth Half-year Results EIB Financing MaaT013 Efficiency Clinigen Agreement
PRESS RELEASE published on 09/17/2025 at 07:30, 7 months 24 days ago Informations privilégiées / Information sur chiffre d’affaires annuel MaaT Pharma publie ses résultats semestriels 2025 et réalise un point sur ses activités, incluant des résultats positifs d'essais cliniques et des accords stratégiques, renforçant sa position financière et opérationnelle Résultats Semestriels Essais Cliniques Position Financière MaaT Pharma Accords Stratégiques
PRESS RELEASE published on 09/17/2025 at 07:30, 7 months 24 days ago Inside Information / Information on annual revenues MaaT Pharma presents positive Half Year 2025 Results with promising data from Phase 3 trial of MaaT013 in aGvHD. Company strengthens position with partnerships and financing Partnerships Phase 3 Trial Half Year Results MaaT Pharma AGvHD
BRIEF published on 07/28/2025 at 07:35, 9 months 14 days ago MaaT Pharma Secures €37.5 Million Loan to Boost Hemato-Oncology Programs Clinical Development EIB Loan Hemato-oncology Microbiome Therapy Xervyteg® Approval
BRIEF published on 07/28/2025 at 07:35, 9 months 14 days ago MaaT Pharma obtient un prêt de 37,5 millions d'euros pour dynamiser ses programmes d'hémato-oncologie Développement Clinique Prêt De La BEI Hémato-oncologie Thérapie Du Microbiome Approbation De Xervyteg®
Published on 05/11/2026 at 13:15, 13 minutes ago Grande Portage Resources Upgrades to OTCQX Best Market
Published on 05/11/2026 at 13:00, 28 minutes ago Re-Assays of 2022 Drill Results Confirm Material Improvements of Vanadium, Gallium, Scandium and Chromium at La Blache
Published on 05/11/2026 at 13:00, 28 minutes ago Eagle Plains Partner Earthwise Commences Drill Program at the Iron Range Precious Metals Project, SE BC
Published on 05/11/2026 at 13:00, 28 minutes ago Earthwise Minerals Begins Drill Program at the Iron Range Gold Project to Define and Expand Mineralization
Published on 05/11/2026 at 13:00, 28 minutes ago AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
Published on 05/11/2026 at 13:13, 15 minutes ago Enapter AG presents new “Stack 250” stack generation for hydrogen production in the multi-megawatt range
Published on 05/11/2026 at 12:50, 38 minutes ago IFAT Munich 2026: Vary Tech, Evonik and SupeZET Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality PPO and Circular Naphtha
Published on 05/11/2026 at 12:15, 1 hour 13 minutes ago ams OSRAM sells CMOS Image Sensor business to indie Semiconductor Inc. for EUR 40 million in cash, further concentrating its growth investments into AI Photonics and AR smart glasses
Published on 05/11/2026 at 11:36, 1 hour 52 minutes ago LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 2 hours 11 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 10:48, 2 hours 40 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 2 hours 40 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 4 hours 12 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 18 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 18 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote